CAD 0.01
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 23.28 Million CAD | 8.36% |
2022 | 21.48 Million CAD | 6.79% |
2021 | 20.12 Million CAD | -25.84% |
2020 | 27.13 Million CAD | 10.9% |
2019 | 24.46 Million CAD | 461.64% |
2018 | 4.35 Million CAD | 50.71% |
2017 | 2.89 Million CAD | 308.51% |
2016 | 707.56 Thousand CAD | 1469.62% |
2015 | 45.07 Thousand CAD | 158.63% |
2014 | 17.43 Thousand CAD | -82.29% |
2013 | 98.4 Thousand CAD | 34.43% |
2012 | 73.2 Thousand CAD | 71.87% |
2011 | 42.59 Thousand CAD | -49.23% |
2010 | 83.88 Thousand CAD | 287.54% |
2009 | 21.64 Thousand CAD | 85.8% |
2008 | 11.65 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 24.42 Million CAD | 4.89% |
2024 Q3 | 22.83 Million CAD | 3.7% |
2024 Q2 | 22.01 Million CAD | -9.84% |
2023 Q3 | 22.38 Million CAD | 2.93% |
2023 Q2 | 21.75 Million CAD | -2.93% |
2023 FY | 23.28 Million CAD | 8.36% |
2023 Q1 | 22.4 Million CAD | 4.29% |
2023 Q4 | 23.28 Million CAD | 3.99% |
2022 Q3 | 22.45 Million CAD | 6.35% |
2022 Q1 | 20.41 Million CAD | 1.48% |
2022 FY | 21.48 Million CAD | 6.79% |
2022 Q4 | 21.48 Million CAD | -4.3% |
2022 Q2 | 21.11 Million CAD | 3.39% |
2021 Q4 | 20.12 Million CAD | 4.29% |
2021 FY | 20.12 Million CAD | -25.84% |
2021 Q2 | 24.65 Million CAD | -7.7% |
2021 Q1 | 26.71 Million CAD | -1.54% |
2021 Q3 | 19.29 Million CAD | -21.75% |
2020 Q3 | 27.8 Million CAD | 7.65% |
2020 FY | 27.13 Million CAD | 10.9% |
2020 Q2 | 25.83 Million CAD | -0.77% |
2020 Q4 | 27.13 Million CAD | -2.44% |
2020 Q1 | 26.03 Million CAD | 6.41% |
2019 Q4 | 24.46 Million CAD | 76.88% |
2019 Q1 | 14.99 Million CAD | 244.22% |
2019 Q2 | 15.1 Million CAD | 0.75% |
2019 Q3 | 13.83 Million CAD | -8.44% |
2019 FY | 24.46 Million CAD | 461.64% |
2018 FY | 4.35 Million CAD | 50.71% |
2018 Q4 | 4.35 Million CAD | 19.47% |
2018 Q2 | 3.73 Million CAD | -53.36% |
2018 Q1 | 8 Million CAD | 177.11% |
2018 Q3 | 3.64 Million CAD | -2.39% |
2017 Q2 | 1.04 Million CAD | 30.32% |
2017 FY | 2.89 Million CAD | 308.51% |
2017 Q4 | 2.89 Million CAD | 193.66% |
2017 Q1 | 805.37 Thousand CAD | 13.82% |
2017 Q3 | 984.3 Thousand CAD | -6.21% |
2016 FY | 707.56 Thousand CAD | 1469.62% |
2016 Q1 | 113.17 Thousand CAD | 130.79% |
2016 Q2 | 416.15 Thousand CAD | 267.7% |
2016 Q3 | 527.66 Thousand CAD | 26.79% |
2016 Q4 | 707.56 Thousand CAD | 34.09% |
2015 Q1 | 260.00 CAD | -98.02% |
2015 Q3 | 42.68 Thousand CAD | 144.91% |
2015 Q2 | 17.43 Thousand CAD | 6603.85% |
2015 Q4 | 49.04 Thousand CAD | 14.88% |
2015 FY | 45.07 Thousand CAD | 158.63% |
2014 Q3 | 111.95 Thousand CAD | 13.77% |
2014 FY | 17.43 Thousand CAD | -82.29% |
2014 Q2 | 98.4 Thousand CAD | 27.68% |
2014 Q4 | 13.13 Thousand CAD | -88.26% |
2014 Q1 | 77.06 Thousand CAD | -15.31% |
2013 Q4 | 91 Thousand CAD | -1.59% |
2013 Q2 | 73.2 Thousand CAD | 148.35% |
2013 FY | 98.4 Thousand CAD | 34.43% |
2013 Q1 | 29.47 Thousand CAD | 164.67% |
2013 Q3 | 92.47 Thousand CAD | 26.33% |
2012 Q4 | 11.13 Thousand CAD | -77.69% |
2012 Q1 | 95.83 Thousand CAD | -75.73% |
2012 Q2 | 42.59 Thousand CAD | -55.56% |
2012 Q3 | 49.91 Thousand CAD | 17.19% |
2012 FY | 73.2 Thousand CAD | 71.87% |
2011 Q2 | 83.88 Thousand CAD | 2752.3% |
2011 Q3 | 10.23 Thousand CAD | -87.8% |
2011 Q4 | 394.78 Thousand CAD | 3757.95% |
2011 FY | 42.59 Thousand CAD | -49.23% |
2011 Q1 | 2941.00 CAD | -91.4% |
2010 Q4 | 34.18 Thousand CAD | -2.97% |
2010 Q2 | 21.64 Thousand CAD | 1989.38% |
2010 FY | 83.88 Thousand CAD | 287.54% |
2010 Q3 | 35.23 Thousand CAD | 62.76% |
2010 Q1 | 1036.00 CAD | 0.0% |
2009 Q4 | 1036.00 CAD | -93.09% |
2009 FY | 21.64 Thousand CAD | 85.8% |
2009 Q1 | 12.56 Thousand CAD | -60.5% |
2009 Q3 | 14.98 Thousand CAD | 0.0% |
2008 FY | 11.65 Thousand CAD | 0.0% |
2008 Q4 | 31.82 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | -692.879% |
Ayurcann Holdings Corp. | 14.31 Million CAD | -62.601% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -4846.196% |
The BC Bud Corporation | 626 Thousand CAD | -3619.286% |
BioNxt Solutions Inc. | 6.55 Million CAD | -255.452% |
CordovaCann Corp. | 11.29 Million CAD | -106.209% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | -173.884% |
Captor Capital Corp. | 28.76 Million CAD | 19.057% |
City View Green Holdings Inc. | 3.73 Million CAD | -523.709% |
1CM Inc. | 9.42 Million CAD | -147.068% |
Global Hemp Group Inc. | 5.82 Million CAD | -299.696% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -9.959% |
IM Cannabis Corp. | 35.11 Million CAD | 33.692% |
Lobe Sciences Ltd. | 2.45 Million CAD | -846.606% |
Maple Leaf Green World Inc. | 10.08 Million CAD | -130.959% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -8924.372% |
Nextleaf Solutions Ltd. | 4.4 Million CAD | -428.753% |
Ovation Science Inc. | 728.99 Thousand CAD | -3093.846% |
Pharmadrug Inc. | 2.92 Million CAD | -695.868% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | -1014.571% |
RAMM Pharma Corp. | 2.83 Million CAD | -721.118% |
RIV Capital Inc. | 275.63 Million CAD | 91.553% |
Revive Therapeutics Ltd. | 3.4 Million CAD | -583.999% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | 93.615% |
SLANG Worldwide Inc. | 37.58 Million CAD | 38.049% |
Red Light Holland Corp. | 3.82 Million CAD | -509.235% |
Top Strike Resources Corp. | 20.99 Million CAD | -10.903% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -2847.368% |
Adastra Holdings Ltd. | 17.65 Million CAD | -31.857% |